These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20102270)

  • 21. Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature.
    Cortese A; Baldanti F; Tavazzi E; Carnevale L; Minoli L; Lozza A; Marchioni E
    J Neurol Sci; 2012 Jan; 312(1-2):173-6. PubMed ID: 22000408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.
    Verity C; Stellitano L; Winstone AM; Andrews N; Stowe J; Miller E
    Lancet; 2011 Oct; 378(9802):1545-6. PubMed ID: 22035553
    [No Abstract]   [Full Text] [Related]  

  • 24. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
    Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
    Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
    Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
    BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
    Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
    Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
    Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California.
    Glaser CA; Winter K; DuBray K; Harriman K; Uyeki TM; Sejvar J; Gilliam S; Louie JK
    Clin Infect Dis; 2012 Aug; 55(4):514-20. PubMed ID: 22573853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pandemic (H1N1) 2009 influenza.
    Polkinghorne B; Ward K; Totaro R
    N S W Public Health Bull; 2010; 21(1-2):41-2. PubMed ID: 21367344
    [No Abstract]   [Full Text] [Related]  

  • 30. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(34):941-7. PubMed ID: 19730406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of childhood Guillain-Barré syndrome as a cause of acute flaccid paralysis in Honduras: 1989-1999.
    Molinero MR; Varon D; Holden KR; Sladky JT; Molina IB; Cleaves F
    J Child Neurol; 2003 Nov; 18(11):741-7. PubMed ID: 14696900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-Barré syndrome after exposure to influenza virus.
    Lehmann HC; Hartung HP; Kieseier BC; Hughes RA
    Lancet Infect Dis; 2010 Sep; 10(9):643-51. PubMed ID: 20797646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
    Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
    BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Kurtis HJ; dos Santos T; Danovaro-Holliday MC; Ruiz-Matus C
    Vaccine; 2012 Jan; 30(5):916-21. PubMed ID: 22155136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.
    Crawford NW; Cheng A; Andrews N; Charles PG; Clothier HJ; Day B; Day T; Gates P; Macdonell R; Roberts L; Rodriguez-Casero V; Wijeratne T; Kiers L
    Med J Aust; 2012 Nov; 197(10):574-8. PubMed ID: 23163689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
    Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
    Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guillain-Barré syndrome secondary to H1N1 influenza vaccine].
    López Nieto M; Gómez Garrido J; Losa Palacios A; Aguila Manso G
    Rev Clin Esp; 2010 Oct; 210(9):485-6. PubMed ID: 20832792
    [No Abstract]   [Full Text] [Related]  

  • 39. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What we know about influenza vaccine and Guillain-Barré syndrome.
    Enos L
    Oreg Nurse; 2009 Nov; ():5. PubMed ID: 19998739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.